Want to join the conversation?
$AMGN, the world's largest biotech company, raised its FY15 outlook. For FY15, revenue is expected to be $21.4-21.6Bil and adjusted EPS is anticipated to be $9.95-10.10 compared to $AMGN's previous estimate of $21.1-21.4Bil and $9.55-9.80, respectively. For FY16, $AMGN expects revenue to be $21.7-22.3Bil and adjusted EPS to be $10.35-10.75.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!